Tuberculosis is responsible for 2 million deaths every year. Even after decades of research, there are still numerous gaps in our understanding of the mechanisms that provide protection against tuberculosis in humans. In this proposal, we take a unique multipronged systems biology approach, combining a non-human primate model of M. tuberculosis infection that closely mimics all aspects of human M. tuberculosis infection, with a vaccine that is only partially effective (resulting in protected and non-protected animals), and state-of- the-art live animal imaging, immunologic monitoring, and computational models, to identify and predict the immunologic mechanisms that are protective against TB. This proposal will develop a multi-disciplinary """"""""tool- box"""""""" for dissecting human immune responses that provide protection against bacterial infections, even beyond TB. We build on considerable experience in computational modeling of tuberculosis and will generate a first- time 3 physiologic compartment model of blood, lung, lymph node with multi-scale interactions (molecular to cellular to organ to host scales), incorporating data generated in this project from the non-human primate, as well as our previous data and that from the literature. These models will be used to identify surrogate markers of protection, which will be used to predict the animals that are protected by this vaccine. In turn, the experimental animals will be the source of granuloma and lymph node tissue to probe the actual protective responses at the site of infection, studies that are impossible to do in humans. Through iteration between computational and experimental models, we will identify the factors that together can contribute to a protective immune response. These studies are a necessary step to a more detailed understanding of host immune responses protective against tuberculosis, and development and testing of new therapeutic and intervention strategies to prevent this disease.

Public Health Relevance

Tuberculosis is a deadly infection that kills 2 million people every year, despite availability of drugs to treat the disease. This systems biology proposal combines computational and experimental approaches to identify the host immune responses that can be exploited to control this infection and protect humans against disease. These studies will identify mechanisms to target for new intervention or therapeutic strategies against tuberculosis.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-VH-D (50))
Program Officer
Peavy, Hannah H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
Schools of Medicine
United States
Zip Code
Cadena, Anthony M; Flynn, JoAnne L; Fortune, Sarah M (2016) The Importance of First Impressions: Early Events in Mycobacterium tuberculosis Infection Influence Outcome. MBio 7:e00342-16
Pienaar, Elsje; Matern, William M; Linderman, Jennifer J et al. (2016) Multiscale Model of Mycobacterium tuberculosis Infection Maps Metabolite and Gene Perturbations to Granuloma Sterilization Predictions. Infect Immun 84:1650-69
DiFazio, Robert M; Mattila, Joshua T; Klein, Edwin C et al. (2016) Active transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosis. Fibrogenesis Tissue Repair 9:6
Warsinske, Hayley C; Wheaton, Amanda K; Kim, Kevin K et al. (2016) Computational Modeling Predicts Simultaneous Targeting of Fibroblasts and Epithelial Cells Is Necessary for Treatment of Pulmonary Fibrosis. Front Pharmacol 7:183
Marino, Simeone; Gideon, Hannah P; Gong, Chang et al. (2016) Computational and Empirical Studies Predict Mycobacterium tuberculosis-Specific T Cells as a Biomarker for Infection Outcome. PLoS Comput Biol 12:e1004804
Gideon, Hannah P; Skinner, Jason A; Baldwin, Nicole et al. (2016) Early Whole Blood Transcriptional Signatures Are Associated with Severity of Lung Inflammation in Cynomolgus Macaques with Mycobacterium tuberculosis Infection. J Immunol 197:4817-4828
Cilfone, N A; Pienaar, E; Thurber, G M et al. (2015) Systems Pharmacology Approach Toward the Design of Inhaled Formulations of Rifampicin and Isoniazid for Treatment of Tuberculosis. CPT Pharmacometrics Syst Pharmacol 4:e00022
Pienaar, Elsje; Cilfone, Nicholas A; Lin, Philana Ling et al. (2015) A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment. J Theor Biol 367:166-79
Cilfone, Nicholas A; Ford, Christopher B; Marino, Simeone et al. (2015) Computational modeling predicts IL-10 control of lesion sterilization by balancing early host immunity-mediated antimicrobial responses with caseation during mycobacterium tuberculosis infection. J Immunol 194:664-77
Ziraldo, Cordelia; Gong, Chang; Kirschner, Denise E et al. (2015) Strategic Priming with Multiple Antigens can Yield Memory Cell Phenotypes Optimized for Infection with Mycobacterium tuberculosis: A Computational Study. Front Microbiol 6:1477

Showing the most recent 10 out of 37 publications